Collagen-coated tissue-based membranes
View Patent ↗A collagen-coated tissue-based membrane that is smooth on both sides so as to inhibit cell and tissue adhesion. The tissue-based membrane is a serous membrane having a fibrous surface and a smooth surface and the collagen is coated on the fibrous surface. Also provided are methods for making the collagen-coated tissue-based membrane.
1. A tissue-based coated membrane, comprising a serous membrane and a type I collagen coating, wherein the serous membrane has a fibrous surface and a smooth surface, the type I collagen coating, having a thickness of 5 μm to 100 μm, is in contact with the fibrous surface, wherein the type I collagen coating is present as a single layer, the type I collagen-coated fibrous surface being smooth, and both the type I collagen-coated fibrous surface and the smooth surface adhere poorly to cells and tissues.
2. The tissue-based membrane of claim 1 , wherein the serous membrane is pericardium, peritoneum, amnion, small intestine submucosa, pleural, or vaginal tunics.
3. The tissue-based membrane of claim 1 , wherein the serous membrane is pericardium or peritoneum.
4. A biocompatible collagen-coated serous membrane prepared by the steps of:
scraping a fibrous side of a serous membrane to remove adhering fibers;
treating the serous membrane to remove cells, lipids, and extractable blood and non-collagenous molecules;
freeze-drying the treated serous membrane;
compressing the fibrous side of the serous membrane;
coating type I collagen onto the fibrous side of the serous membrane, thereby rendering the fibrous side of the serous membrane smooth, wherein the type I collagen is coated onto the fibrous side of the serous membrane in a single layer; and
exposing the type I collagen-coated serous membrane to a crosslinking agent to effect crosslinking,
wherein the type I collagen coating has a thickness of 5 μm to 100 μm.
5. A biocompatible collagen-coated serous membrane prepared by the steps of:
scraping a fibrous side of a serous membrane to remove adhering fibers;
treating the serous membrane to remove cells, lipids, and extractable blood and non-collagenous molecules;
freeze-drying the treated serous membrane;
compressing the fibrous side of the serous membrane;
spraying a collagen coat onto the fibrous side of the serous membrane, thereby rendering the fibrous side of the serous membrane smooth, wherein the collagen coat is sprayed onto the fibrous side of the serous membrane in a single layer; and
exposing the collagen-coated serous membrane to a crosslinking agent to effect crosslinking,
wherein the serous membrane is pericardium or peritoneum, the collagen coating has a thickness of 5 μm to 100 μm, and the collagen is type I collagen.